17 July 2012 - AstraZeneca, a UK-based pharmaceutical and biologics company, reported today that it has informed its former chief executive that his share bonuses for 2011 and 2012 are to be forfeited from his retirement settlement.

David Brennan announced earlier this year that he would st...

 

 

 

You must be logged in to view the whole article.
Click here if you require signing up